骨髓性/自然杀手 (NK) 细胞前体急性白血病作为一种独特的白血病类型
Akira Nishimura1, Kazuaki Yokoyama2, Takuya Naruto1
1Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
骨髓性/自然杀手细胞前体急性白血病 (MNKPL) 是一种独特的白血病亚型. 研究人员确定了关键的分子特征和潜在的治疗点,包括l-asparaginase敏感性.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 骨髓性/自然杀手 (NK) 细胞前体急性白血病 (MNKPL) 呈现出独特的临床和免疫类型特征.
- 缺乏明确的分子特性和稀有性阻碍了MNKPL识别的共识.
- 目前对MNKPL的治疗结果是不理想的,即使是输血细胞移植.
研究的目的:
- 使用多组学分析阐明MNKPL的独特分子特征.
- 调查NK细胞和MNKPL中的骨髓细胞的血统起源.
- 为了确定MNKPL的潜在治疗策略.
主要方法:
- 多组学分析包括单细胞分析.
- 对基因表达模式的研究 (NOTCH1,RUNX3,BCL11B).
- 在体外药物敏感性测试中,重点关注l-asparaginase和阿斯巴拉金合成酶 (ASNS).
主要成果:
- 在分子上,MNKPL与急性骨髓性白血病,T细胞急性淋巴细胞白血病和混合表型急性白血病 (MPAL) 有着很大的区别.
- MNKPL的特征包括NOTCH1和RUNX3的激活,以及BCL11B的下调.
- 单细胞分析表明,在MNKPL.中NK和骨髓状细胞系的共享原始细胞.
- MNKPL细胞对l-asparaginase的敏感性增加,ASNS水平降低.
结论:
- MNKPL代表了一个独特的白血病实体,具有特定的分子特征.
- 证据表明,MNKPL中NK和髓状细胞的共同祖先.
- 对l-asparaginase的敏感性增加为MNKPL治疗提供了一个有希望的治疗途径.
更多相关视频
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
08:00A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model
Published on: October 14, 2016
相关概念视频
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Differentiation of Common Myeloid Progenitor Cells
Lineage Commitment
Classification of Leukocytes
Neutrophils are the most abundant type of granular leukocytes, comprising 50-70% of all leukocytes. They feature small, evenly distributed granules and a...
Cells of the Adaptive Immune Response
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
